These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20184937)

  • 21. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
    Bocchetta A; Siddu A; Sardu C; Sarnicola A; Martinelli V
    J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
    Al-sharefi A; Bilous R
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26336183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate-induced hyperammonemic encephalopathy.
    Bhatia H; Raman PG
    J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
    [No Abstract]   [Full Text] [Related]  

  • 24. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
    Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ
    Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N; Landry KB; Fargason RE; Birur B
    Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Valproate-induced hyperammononemic encefalopathy].
    Scarano V; Bellarosa I; Bertogliatti S; Terracciano AM; Orlando V
    Recenti Prog Med; 2010 Dec; 101(12):480-2. PubMed ID: 21394985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infiltration of sodium valproate with compartment syndrome and bullous reaction: case report and literature review.
    Santivasi WL; Kulkarni S; Patton ML; Haith LR; Guilday RE; Reigart CL; Ackerman BH
    Burns; 2011 Nov; 37(7):e59-62. PubMed ID: 21715098
    [No Abstract]   [Full Text] [Related]  

  • 28. Valproate-induced hyperammonemic encephalopathy: a case report.
    Shah S; Wang R; Vieux U
    J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment.
    Reif A; Hamelbeck B; Pfuhlmann B
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):356-7. PubMed ID: 12673616
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
    Kimmel RJ; Irwin SA; Meyer JM
    Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The history of valproate in clinical neuroscience.
    Henry TR
    Psychopharmacol Bull; 2003; 37 Suppl 2():5-16. PubMed ID: 14624229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 34. Valproate-induced tinnitus misinterpreted as psychotic symptoms.
    Reeves RR; Mustain DW; Pendarvis JE
    South Med J; 2000 Oct; 93(10):1030-1. PubMed ID: 11147471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The real mechanism of VPA-induced hyperammonemia remains unknown.
    Hung CC; Li TM; Wei IH; Huang CC
    Gen Hosp Psychiatry; 2011; 33(1):84.e3-4. PubMed ID: 21353142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
    Sonik P; Hilty DM; Rossaro L; Bourgeois JA
    J Clin Psychopharmacol; 2011 Oct; 31(5):680-2. PubMed ID: 21881462
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe leukopenia with valproate.
    Storch DD
    J Am Acad Child Adolesc Psychiatry; 2000 Oct; 39(10):1208-9. PubMed ID: 11026170
    [No Abstract]   [Full Text] [Related]  

  • 38. Valproate-induced hyperammonemia and seizures: perioperative concerns.
    Garg R; Sunder RA
    Paediatr Anaesth; 2011 Oct; 21(10):1084-5. PubMed ID: 21981101
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
    Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
    Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.